Tyrosine hydroxylase antisense gene therapy causes hypotensive effects in the spontaneously hypertensive rats.
We investigated the effect of antisense oligodeoxynucleotides (AS ODN) against tyrosine hydroxylase (TH) on hypertension and sympathetic nervous system activity in spontaneously hypertensive rats (SHR). Systolic blood pressure (SBP) in SHR treated with TH AS ODN (50, 200 microg/rat, i.v.) was significantly lower than that of control SHR. Epinephrine and norepinephrine levels, TH activity, and TH protein levels in the adrenal medulla of SHR were reduced concomitant with TH AS ODN treatment-induced changes in SBP. In contrast, TH AS ODN (200 microg/rat) had no effect on SBP in Wistar-Kyoto rats (WKY), despite significantly decreased catecholamine levels, TH activity, and TH protein levels. These findings suggest that peripheral systemic injection of TH AS ODN may be effective as hypotensive therapy in SHR.
Kumai
T
T
Department of Pharmacology, St Marianna University School of Medicine, Kawasaki-shi, Japan. yakuri@marianna-u.ac.jp
Tateishi
T
T
Tanaka
M
M
Watanabe
M
M
Shimizu
H
H
Kobayashi
S
S
D000313:Adrenal Medulla / Q000378:metabolism; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D002395:Catecholamines / Q000378:metabolism; D003971:Diastole; D015316:Genetic Therapy; D008297:Male; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D051381:Rats; D011918:Rats, Inbred SHR / Q000502:physiology*; D011921:Rats, Inbred WKY / Q000502:physiology; D013599:Systole; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics* / Q000378:metabolism
D002395:Catecholamines; D016376:Oligonucleotides, Antisense; D014446:Tyrosine 3-Monooxygenase